Skip to main content
OCSL logo

OCSL · Oaktree Specialty Lending Corp

Track OCSL — free
$11.72 -0.11 (-0.93%) At close · Nov 20
Market Cap
$1.03B
Shares
88.09M
Volume · Nov 20 614.84K Avg daily vol (3M) 449.02K

Price & Indicators

 

Key stats

Close
$11.72
Fri 20 Nov
Open
$11.83
Fri 20 Nov
Average volume, 30 days
448K
shares a session
Short interest
3.1M
3.6% of shares · 7.5 days to cover
Day range
$11.70$11.90
Open $11.83 Close $11.72
52-week closing range
$10.78$13.80
Close $11.72 15.1% under the high
Short volume, last session
47%
Last earnings
Nov 17, 2026
Latest filing
10-K · Nov 17
Price history
Jan 2020 to Nov 2026

Up next

Feb 3, 2027 Est · unconfirmed · in 10 wks

Latest documents

2026
Nov 17
Earnings call
Non-accruals fall to 1.8% of debt portfolio at fair value

Oaktree Specialty Lending reported adjusted net investment income of $29.6 million, or $0.34 per share, down from $32.2 million, or $0.37 per share in the prior quarter. Non-accruals fell to approximately 1.8% of the total debt portfolio at fair value, with dollar amounts down from $81 million a year ago to $45 million. The company priced $300 million of five-year unsecured notes due 2031 with a 7% coupon.

4 source passages
adjusted net investment income was $29.6 million, or approximately $0.34 per share, down from $32.2 million, or $0.37 per share in the prior quarter non-accruals were approximately 1.8% of the total debt portfolio at fair value non-accruals at fair value have fallen from $81 million a year ago to $45 million today we priced $300 million of five-year unsecured notes due 2031 with a 7% coupon Open the document at this passage
Nov 17
Current report 8-K
Net Investment Income Falls to $0.34 Per Share; NAV $15.63

Oaktree Specialty Lending's fourth-quarter net investment income fell to $0.34 per share from $0.37, and NAV per share dropped to $15.63. It declared a $0.30 quarterly distribution plus a $0.02 supplemental distribution, payable December 31, 2026.

Financial results Read from the first part of this long document
3 source passages
GAAP net investment income was $29.8 million ($0.34 per share) and $133.4 million ($1.51 per share) for the fourth fiscal quarter and full year of 2026, as compared with $32.5 million ($0.37 per share) Net asset value (“NAV”) per share was $15.63 as of September 30, 2026, compared with $15.70 and $16.64 as of June 30, 2026 and September 30, 2025, respectively. Quarterly and supplemental cash distributions were declared of $0.30 per share and $0.02 per share, respectively, payable in cash on December 31, 2026 to stockholders of record on December 15, 2026. Open the document at this passage
Nov 17
Annual report 10-K FY2026, ended Sep 30
Fair value of investments falls to $2,706.4 million

Oaktree Specialty Lending reports investments at fair value of $2,706.4 million at September 30, 2026, down from $2,847.8 million, primarily from repayments and net realized and unrealized losses.

Net income $40.29M ▲ 18.8% Diluted EPS $0.46 ▲ 17.9%
Read from the MD&A section
Source passage
As of September 30, 2026, we held $2,706.4 million of investments at fair value, down from $2,847.8 million held at September 30, 2025, primarily driven by investment repayments and net realized and unrealized losses during the year ended September 30, 2026. Open the document at this passage
All documents

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$283.12M
Trailing 12 months
Net income (TTM)
$40.28M
Trailing 12 months
Revenue growth YoY
-11.8%
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
25.5
Trailing earnings · reciprocal yield 3.9%
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
−$1.34B
Latest balance sheet
Dividend yield
12.5%
Trailing 12 months
Shares change YoY
+0.0%
Year over year
Price change (1Y)
-11.1%
Trailing year
Short interest
3.6%
Latest settlement · 7.5 days to cover
View all 125 metrics

AI Brief

Q4 FY26 earnings call · Nov 17, 2026
Q4 FY26

TL;DR. Non-accruals fell 44% year over year, and the September notes drew strong demand while floating-rate exposure should help net investment income after the rate hike. Adjusted net investment income fell both quarterly and for the full year, Pluralsight was added to non-accrual, and the quarter carried $7.0 million of realized and unrealized losses.

Bullish
  • + Non-accruals at fair value fell 44%, from $81 million a year ago to $45 million. new
  • + September $300 million unsecured notes priced with strong demand and a final order book more than three times the deal size. new
  • + Floating-rate exposure means the September rate hike is expected to lift net investment income, with the net impact positive. new
  • + FDA approval for BioExcel's drug triggered the full $67.5 million additional milestone to the lenders. new
  • + Moody's revised the ratings outlook to stable and kept the BAA3 rating unchanged. new
Bearish
  • − Adjusted net investment income fell to $29.6 million, or $0.34 per share, from $32.2 million, or $0.37 per share, in the prior quarter.
  • − Full-year adjusted net investment income fell to $131.7 million, or $1.49 per share, from $151.3 million, or $1.76 per share.
  • − Pluralsight's first-out term loan was added to non-accrual as the company continues to underperform. new
  • − Adjusted total investment income decreased $1.1 million in the quarter, driven by a lower average portfolio balance. new
  • − The quarter had adjusted net realized and unrealized losses of $7.0 million on certain debt and equity investments.
  • − BioXL Therapeutics was added to non-accrual this quarter as a new borrower. new

AI-generated from the earnings call and 8-K · may contain errors · not investment advice

Equibles Rating

blended score · not investment advice
Overall
Neutral
SellHoldBuy
Technical Sell Momentum Neutral Sentiment Neutral Fundamentals Weak Quant / Vol Low
Market backdrop VIX 35.9 · fear Equity put/call 0.77
Technical
price trend
Sell
50 / 200-day cross Death cross
Price vs 200-day avg −3%
below
Price vs 50-day avg −2%
below
RSI (14) 41
neutral
MACD trend Negative
52-week position 31%
mid-range
Momentum
relative strength
Neutral
1-month return +2%
trailing
6-month return −4%
trailing
YTD return −8%
this year
Relative strength +5%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) Death cross
50d $12 › 200d $12 — 200d above 50d
Institutional flow Accumulating
+1% holders QoQ · +20 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
3.56% of shares out · ▼ -1.3% MoM · 7.5 days cover
Volume signal Reversal watch
High volume on a down day — possible exhaustion
Institution breadth Multi-yr low
172 holders — near 3-yr low, contrarian setup
Squeeze score 65
elevated · 0–100
Fundamentals
Weak
EPS growth +18%
Y/Y
Valuation P/E 25.5
rich
Balance sheet $1.3B
net debt
Quant / Vol
risk profile
Low
Volatility 24%
annualized · 1-yr
Max drawdown −22%
past year
ATR 2.6%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Latest guidance · from the 8-K filed Aug 1, 2024
annually
Net investment income per share increase from base management fe $0.15
quarter
Net investment income per share increase from base management fe $0.03 – $0.04
Previous outlook earlier release · from the 8-K filed Apr 30, 2024

Still-open targets the latest release did not restate under the same label.

Net investment income per share increase · annually $0.15
Net investment income per share increase · per quarter $0.03 – $0.04
Net investment income per share · annually $0.15

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Sell
2 · 4 · 0
50 / 200-day cross
Death cross Bearish
Price vs 200-day avg
−3% Neutral
Price vs 50-day avg
−2% Neutral
RSI (14)
41 Neutral
MACD trend
Negative Bearish
52-week position
31% Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross) Death cross
50d $12 › 200d $12 — 200d above 50d
Institutional flow Accumulating
+1% holders QoQ · +20 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
3.56% of shares out · ▼ -1.3% MoM · 7.5 days cover
Volume signal Reversal watch
High volume on a down day — possible exhaustion
Institution breadth Multi-yr low
172 holders — near 3-yr low, contrarian setup
Price context
position in its 52-week range
Range low $11 Now $12 · 31% Range high $14
vs 200-day avg -3% vs 50-day avg -2% 50-day below 200-day death cross

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from written earnings releases and filings
Metric Latest Period YoY
GAAP → non-GAAP reconciliation
GAAP Net increase (decrease) in net assets resulting from operations 40.29M
-1.74M Interest income amortization (accretion) related to merger accounting adjustments
+977K Net realized and unrealized gains (losses) related to merger accounting adjustments
= Adjusted earnings (loss) 39.52M
Adjusted Liquidity $815M 9/30/2026 —
GAAP → non-GAAP reconciliation
GAAP GAAP net investment income 133.41M
-1.74M Interest income amortization (accretion) related to merger accounting adjustments
+0K Part II incentive fee
= Adjusted net investment income 131.66M
GAAP → non-GAAP reconciliation
GAAP GAAP net realized and unrealized gains (losses), net of taxes -93.12M
+977K Net realized and unrealized gains (losses) related to merger accounting adjustments
= Adjusted net realized and unrealized gains (losses), net of taxes -92.14M
GAAP → non-GAAP reconciliation
GAAP GAAP total investment income 283.13M
-1.74M Interest income amortization (accretion) related to merger accounting adjustments
= Adjusted total investment income 281.38M
Average portfolio company debt size 16.79M as of September 30, 2026 —
Common shares outstanding at end of period 88.09M Year ended September 30, 2026 filing —
Coupon interest rate (net of effect of interest rate swaps) - 2027 Notes 5.69% the year ended September 30, 2026 filing —
Coupon interest rate (net of effect of interest rate swaps) - 2029 Notes 6.91% the year ended September 30, 2026 filing —
Coupon interest rate (net of effect of interest rate swaps) - 2030 Notes 5.98% the year ended September 30, 2026 filing —
Coupon interest rate (net of effect of interest rate swaps) - 2031 Notes 6.53% the year ended September 30, 2026 filing —
Credit Facilities Committed $1.16B 9/30/2026 —
Credit Facilities Drawn -$166M 9/30/2026 —
Funded investments $910.3M the year ended September 30, 2026 filing —
Investment commitments originated $905.6M the year ended September 30, 2026 filing —
Liquidity $1.04B As of 9/30/2026 —
Net asset value ("NAV") per share $15.63 as of September 30, 2026 —
Net asset value at end of period $21.84 Year ended September 30, 2021 filing —
Net asset value per common share $15.63 fiscal 2026 filing —
Net asset value per share at end of period $15.63 Year ended September 30, 2026 filing —
Net Assets $1.38B 9/30/2026 —
New funded investment activity $162,400 three months ended September 30, 2026 —
Non-accrual investments as a percentage of debt investments at cost 4% as of September 30, 2026 —
Non-accrual investments as a percentage of debt investments at fair value 1.8% as of September 30, 2026 —
Non-accrual investments at fair value 45.03M as of September 30, 2026 —
Number of investments on non-accrual 6 three months ended September 30, 2026 —
Number of new investment commitments in new portfolio companies 12 three months ended September 30, 2026 —
Number of portfolio companies 170 as of September 30, 2026 —
Number of portfolio company exits 31 the year ended September 30, 2026 filing —
Percentage fixed-rate 9% three months ended September 30, 2026 —
Percentage floating-rate 91% as of September 30, 2026 —
PIK interest 6.4% the year ended September 30, 2026 filing —
Pro Forma Adjusted Liquidity $465M 9/30/2026 —
Proceeds from prepayments, exits, other paydowns and sales $973.2M the year ended September 30, 2026 filing —
Total debt outstanding $1.42B as of September 30, 2026 —
Total for the year ended September 30, 2026 (amount per share) $1.47 fiscal 2026 filing —
Total quarterly distributions per share $0.32 quarter ended September 30, 2026 —
Total return (2) 2.76% Year ended September 30, 2026 filing —
Undrawn capacity under credit facility $994M as of September 30, 2026 —
Unfunded Commitments -$226M 9/30/2026 —
Unfunded investment commitments $252.6M as of September 30, 2026 —
Unrestricted cash and cash equivalents $45.1M as of September 30, 2026 —
Weighted average interest rate on debt outstanding 6.2% quarter ended September 30, 2026 —
Weighted average interest rate on Syndicated Facility borrowings 5.73% year ended September 30, 2026 filing —
Weighted average yield on new debt investment commitments 9.6% the fourth quarter (4Q 2026) —
Adjusted net realized and unrealized losses, net of taxes non-GAAP $2.1M Q3 FY2026 —
New investment commitments $206.4M Q3 FY2026 —
Weighted average outstanding debt $1.5B Three months ended June 30, 2026 filing —

Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

Versus peers

Asset Management — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
OCSL
Oaktree Specialty Lending Corp
this stock
$1.03B -8.0% — 25.5 3.6%
BLK
BlackRock, Inc.
$178.51B +2.9% +16.2% 25.1 1.3%
BN
BROOKFIELD Corp
$84.03B -17.7% — — 1.0%
BX
Blackstone Inc.
$83.22B -28.1% +9.2% 24.7 2.6%
KKR
KKR & Co. Inc.
$78.99B -30.5% -11.0% — 1.6%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
172
% held
50.4%
Net QoQ
+1.6M sh
Top holder
BROOKFIELD Corp /ON/
Held Float
View
Held by Funds
Fund positions
14
View
Short & Settlement
Short Interest Falling
Shares short
3.1M
Days to cover
7.5d
Change
-41.6K sh
View
Short Volume
Short vol %
47%
As of
Nov 20, 2026
Short Total
View
Fails to Deliver
FTD shares
101
Value
$1.2K
As of
Oct 29, 2026
View
Off-Exchange
Off-exchange %
43.1%
Week of
Oct 12, 2026
Off-exch Lit
View
Financials
Financials
Net income (FY)
$40.3M
EPS diluted
$0.46
View
Filings
SEC Filings
Latest
8-K
Filed
Nov 17, 2026
This year
16

Oaktree Specialty Lending's fourth-quarter net investment income fell to $0.34 per share from $0.37, and NAV per share dropped to $15.63. It declared a $0.30 quarterly distribution plus a $0.02 supplemental distribution, payable December 31, 2026.

View
Earnings & Events
Webcasts
Last webcast
Nov 17, 2026
View
Investor Relations
Latest news
Oaktree Specialty Lending Corpora…
Published
Nov 17, 2026
View

Performance

5D 20D 120D MTD YTD
OCSL -3.6% +2.5% -3.7% -3.5% -8.0%
SPY -8.6% -9.2% -9.2% -8.7% +1.2%
vs SPY +4.9% +11.7% +5.5% +5.3% -9.2%

Capital returns

Latest dividend
$0.33 / share · ex Sep 15, 2026
Declared · upcoming
$0.32 / share · ex Dec 15, 2026
Cut 2.9%
Paid (TTM)
$1.47 / share · 4 payouts
Dividend yield (TTM, derived)
12.54%
Full dividend history

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 1414932 CUSIP 67401P405 13F (30d) 178 filings 154 filers Visit website Investor relations